People · Operator
Named in public records as an officer, director or promoter · active 2013–2020 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Transverse Medical Inc. | — | Healthtech | Series A | $27.5M | $43.4M | 2017 |
| Vanquish Oncology, Inc. | — | Biotechnology | Series A | $6.9M | $18.1M | 2013 |
Ted Tarasow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ted Tarasow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Larry Lawson | 1 | 4 |
| Ron Way | 1 | 1 |
| Billie Jo Herberger | 1 | 1 |
| Judd Heberger | 1 | 1 |
| Eric Goslau | 1 | 1 |
| Chad Frederickson | 1 | 1 |
| William Goslau | 1 | 1 |
| Paul Hergenrother | 1 | 1 |
| Judd Herberger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.